SP-MHCI-1226-2

Pyruvate dehydrogenase complex 249-262, GDLLAEIETDKATI

US$169.00

In stock

Description

About Pyruvate dehydrogenase complex 249-262, GDLLAEIETDKATI

The Human Acetyltransferase (Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex ) Peptide (IEDB: 122098) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Acetyltransferase Peptide, H-GDLLAEIETDKATI-OH (Uniprot: P10515 aa: 249-262) from JPT is produced under strict quality control and quality management.

Pyruvate dehydrogenase complex 249-262, GDLLAEIETDKATI - Specifications

  • Peptide sequence: H-GDLLAEIETDKATI-OH
  • Amount: 1 mg
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Myasthenia gravis
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Pyruvate dehydrogenase complex 249-262, GDLLAEIETDKATI

References:
Read References with JPT’s Antigen Peptides

Pyruvate dehydrogenase complex 249-262, GDLLAEIETDKATI has been described in:
Autoreactive T-cell responses in primary biliary cirrhosis are proinflammatory whereas those of controls are regulatory., Hepatol Res, 2007 (PMID: 17931193.0)< br/>CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis., J Autoimmun, 2008 (PMID: 18644699.0)< br/>Peripheral tolerance and the qualitative characteristics of autoreactive T cell clones in primary biliary cirrhosis., J Immunol, 2007 (PMID: 17709548.0)

Documentation

Documentation for Pyruvate dehydrogenase complex 249-262, GDLLAEIETDKATI

Properties

Properties of Pyruvate dehydrogenase complex 249-262, GDLLAEIETDKATI

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Acetyltransferase, Myasthenia gravis
Layout: Freeze-dried in glass vial
Organism: Human
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No

Further Information to Pyruvate dehydrogenase complex 249-262, GDLLAEIETDKATI

Information Values
Sequence: H-GDLLAEIETDKATI-OH
Specifications: 14mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote